Microvascular Rarefaction and Heart Failure With Preserved Ejection Fraction

Frontiers in Cardiovascular Medicine - Switzerland
doi 10.3389/fcvm.2019.00015
Full Text
Abstract

Available in full text

Date
Authors
Publisher

Frontiers Media SA

Related search

Prognosis in Heart Failure With Preserved Ejection Fraction

sudan heart journal
2017English

Spironolactone for Heart Failure With Preserved Ejection Fraction

New England Journal of Medicine
Medicine
2014English

Prognosis of Heart Failure With Stable Mid-Range Ejection Fraction in Comparison to Heart Failure With Stable Reduced Ejection Fraction and Heart Failure With Stable Preserved Ejection Fraction

Journal of Cardiac Failure
Cardiovascular MedicineCardiology
2019English

Influence of Ejection Fraction on Cause-Specific Mortality in Heart Failure With Preserved Ejection Fraction

European Journal of Heart Failure
Cardiovascular MedicineCardiology
2017English

Heart Rate in Heart Failure With Preserved Ejection Fraction: Target or Marker?

European Journal of Heart Failure
Cardiovascular MedicineCardiology
2017English

Treating Heart Failure With Preserved Ejection Fraction: Learning From Pulmonary Fibrosis

European Journal of Heart Failure
Cardiovascular MedicineCardiology
2018English

Riser Pattern: Another Determinant of Heart Failure With Preserved Ejection Fraction

Journal of Clinical Hypertension
Internal MedicineCardiologyEndocrinologyCardiovascular MedicineMetabolismDiabetes
2016English

Cardiac Troponin and Outcome in Decompensated Heart Failure With Preserved Ejection Fraction

Cardiovascular Diagnosis and Therapy
Cardiovascular MedicineCardiology
2017English

Ischaemia in Heart Failure With Preserved Ejection Fraction; Is It Important?

European Journal of Heart Failure
Cardiovascular MedicineCardiology
2016English

Amanote Research

Note-taking for researchers

Follow Amanote

© 2024 Amaplex Software S.P.R.L. All rights reserved.

Privacy PolicyRefund Policy